The Compass
Wednesday February 13, 2002
2
Talk ofECSV
By: Robin Reese
It is that time of the year when love is in the air. My question to ECSU students is:
What do you iooii for in that special someone?
Jewel Milliken:
Freshman
“In that special someone, I look for a
person with a good personality, a sense
of humor, someone who is cute and who
is just all around unique.”
Sharkarian Washington:
Sophomore
“In that special someone, I look for
a sense of humor to keep the
relationship from going stale.
Also I look for trust in a person
because, as we all know, a
relationship is built on trust.”
Chaquella Worthington:
Junior
“In that special someone, I look for a per
son who is canng, sensitive, trustworthy,
honest, intelligent and most important a
one-woman man.”
Jordan Williams:
Senior
“In that special someone, I look for a great
personality, a good heart and someone
who carries herself in a lady-like manner.”
Photos by Inger Parker
ARE YOUR GENES MAKING YOU SICK?
College-Age Students Among a High Risk Population for Developing Ulcerative Colitis
RALEIGH, NC—(COLLEGIATE
PRESSWIRE) A combination of age,
geneaology and genetics make
certain college students a high-risk
population for developing ulcerative
colitis. Characterized by abdominal
pain and diarrhea, ulcerative colitis is
a debilitating disease of the large
intestine that is four to five times
more prevalent among young mem
bers of the Ashkenazi Jewish popu
lation — particularly those in the age
range of 15 to 30.
“Unfortunately, ulcerative colitis
often strikes during one of the most
dynamic periods of youth,” said Gary
Lichtenstein, M.D., director of the
Inflammatory Bowel Disease Center
at the Hospital of the University of
Pennsylvania. “In addition to balanc
ing academics and extracurricular
activities, students diagnosed with
this condition have to contend with
painful and often embarrassing
symptoms that force them to plan
their schedules around the nearest
restroom.”
While there is no cure for ulcer
ative colitis, the recent availability of
Salix Pharmaceuticals’ new prescrip
tion treatment COLAZAL(TM)
(balsalazide disodium) may provide
patients with advantages over exist
ing therapies. As the first FDA-
approved development for the treat
ment of ulcerative colitis in the last
decade, COLAZAL was developed
with a novel formulation that expe
dites delivery of the drug’s active
ingredients to the primary site of
inflammation, the colon.
“This is a fundamentally impor
tant development for the thousands
of young people who suffer with this
disease on a daily basis,” said Dr.
Lichtenstein. “When the disease is
active, symptoms may preclude
students from such everyday activi
ties as attending classes, visiting
friends or simply leaving the house.
Thankfully, this new treatment helps
manage symptoms and induce
remission (an absence of symptoms
attributed to the colitis), which may
help improve the person's overall
quality of life.”
Designed to relieve the symp
toms of ulcerative colitis and induce
remission, COLAZAL delivers the
active anti-inflammatory medication
directly to the colon — the site of
this disease — where it appears to
work topically. With other therapies,
ingredients can be released too
early or sometimes, not at all, caus
ing whole tablets to pass through
the colon.
Expert Advice for People With
Ulcerative Colitis:
Like most chronic diseases.
ulcerative colitis can change your
lifestyle, but it doesn’t have to control
your life. In addition to seeking
proper medical advice and treat
ment, experts encourage students to
educate themselves, their friends,
family members and professors on
the particulars of this disease. Be
cause of the embarrassing nature of
symptoms, students often find it
easier to withdraw from social activi
ties than to explain their condition.
But experts say this withdrawal
creates a sense of isolation that can
have a negative impact on a
person’s overall well-being and
ability to heal.
The Crohn’s and Colitis Foun
dation of America also recommends
the following tips for managing symp
toms and alleviating some of the
stressful feelings that arise when
symptoms flare up.
Controlling the Symptoms of
UC:
* Eat small portions at regular
intervals (every three to four hours)
* Avoid caffeine, foods high in
fiber and raw fruits and vegetables.
* Maintain a regular exercise
program
* Limit alcohol intake — particu
larly when symptoms are active
* Communicate your needs and
feelings with fhends and family
For more information about ulcer
ative colitis and local support groups
designed to help young patients, con
tact the Crohn’s & Colitis Foundation of
America at 800-343-3637 or visit its
web site at http://www.ccfa.org. If you or
your physician would like more informa
tion about COLAZAL, visit Salix Phar
maceuticals’ website at http://
www.salixpharm.com, or call (866) 669-
SLXP (7597).
Salix Pharmaceuticals, Inc., head
quartered in Raleigh, North Carolina, ‘
develops and markets prescription
pharmaceutical products for the treat
ment of gastrointestinal diseases.
Salix’s lead product is COLAZAL.
Source: Salix Pharmaceuticals, Inc.
Contact: Cara Miller
Weber Shandwick Worldwide
212/445-8263
cmiller@webershandwick.com
Transmitted by Collegiate Presswire :
Web: http://www.cpwire.com
Phone:(888)621-7721 ;
Email: info@cpwire.com I